President and CEO of Angiotech Pharmaceuticals Inc. (ANPI) William L Hunter buys 49,500 shares of ANPI on 09/29/2009 at an average price of $1.9 a share.
Angiotech Pharmaceuticals Inc. is a Canadian pharmaceutical company dedicated to the development of medical device coatings and treatments for chronic inflammatory diseases through reformulation of the anticancer drug paclitaxel. These treatments are based upon the company's discovery that paclitaxel blocks an important cellular pathway involved in inflammation. The company's goal is to establish a leadership position in the development of treatments for chronic inflammatory diseases. Angiotech Pharmaceuticals Inc. has a market cap of $146.6 million; its shares were traded at around $1.76 with and P/S ratio of 0.5.
LINK
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment